Quest Diagnostics Incorporated · NYSE:DGX

Doherty Catherine T. sold 22,105 Quest Diagnostics Incorporated shares (Form 4)

Traded Nov 3, 2026 · Filed Nov 5, 2026

On Nov 3, 2026, Doherty Catherine T. (Executive Vice President) sold 22,105 Quest Diagnostics Incorporated shares at an average US$248.02 for US$5.48M under a trading plan, leaving 71,949 shares. Filed Nov 5, 2026 (Form 4).

Sold
22,105 shares
Price
US$248.02 average (US$245.45 to US$251.24)
Value
US$5.48M
Holding after
71,949 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Executive Vice President

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Nov 3, 2026Common StockAward4,82771,949Direct
Nov 3, 2026Common StockOption exercise22,105US$121.8194,054Direct
Nov 3, 2026Common StockSale3,818US$245.4590,236Direct
Nov 3, 2026Common StockSale5,990US$246.2684,246Direct
Nov 3, 2026Common StockSale1,151US$246.9883,095Direct
Nov 3, 2026Common StockSale2,358US$248.3880,737Direct
Nov 3, 2026Common StockSale3,004US$249.4077,733Direct
Nov 3, 2026Common StockSale2,877US$250.4974,856Direct
Nov 3, 2026Common StockSale2,907US$251.2471,949Direct

Source

Download original · View original at SEC

Related